ArticleFrontiers in pharmacology2024

Discovery of novel and highly potent dual-targeting PKMYT1/HDAC2 inhibitors for hepatocellular carcinoma through structure-based virtual screening and biological evaluation.

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.